Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection

Scandinavian Journal of Gastroenterology

Volumn 47, Issue 2, 2012, Pages 155-161

  Petersen, Andreas Munk ^a,b   Schou, Christian ^a   Mirsepasi, Hengameh ^a   Engberg, Jørgen ^c   Friis Møller, Alice ^b   Nordgaard Lassen, Inge ^b   Wildt, Signe ^b   Krogfelt, Karen Angeliki ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c SLAGELSE HOSPITAL   (Denmark)

Author keywords

Escherichia coli; inflammatory bowel disease; Omp C; serology

Indexed keywords

BACTERIUM ANTIBODY; OUTER MEMBRANE PROTEIN C;

ACUTE GASTROENTERITIS; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENTERITIS; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SERODIAGNOSIS;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CHILD; CHRONIC DISEASE; COLITIS, ULCERATIVE; COLONIC POUCHES; CROHN DISEASE; DIARRHEA; DYSENTERY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; GASTROENTERITIS; HUMANS; MALE; MIDDLE AGED; PORINS; POUCHITIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84856042028     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2011.639080     Document Type: Article

References (33)

1. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609-14.
2. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11. (Pubitemid 24195339)
3. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
4. Seibold F, Weber P, Klein R, Berg PA, Wiedmann KH. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing holangitis. Gut 1992;33:657-62.
5. Colombel JF, Reumaux D, Duthilleul P, Noël LH, Gower- Rousseau C, Paris JC, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656-60.
6. Bansi DS, Chapman RW, Fleming KA. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:881-5. (Pubitemid 26319391)
7. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson D, Pennington CR, et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. BMJ 1988;297:1105-6.
8. Sendid B, Colombel JF, Jacquinot PM, Faille C, Fruit J, Cortot A, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996;3:219-26. (Pubitemid 26104780)
9. Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58-63. (Pubitemid 30307678)
10. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol 2004;99:2376-84. (Pubitemid 40039369)
11. Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004;99: 2235-41. (Pubitemid 39524716)
12. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689-99. (Pubitemid 34977074)
13. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13. (Pubitemid 28545991)
14. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherentinvasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21. (Pubitemid 39091889)
15. Kotlowski R, Bernstein CN, Sepehri S, Krause DO. High prevalence of Escherichia coli belonging to the B2+D phylogentic group in inflammatory bowel disease. Gut 2007;56: 669-75. (Pubitemid 46662933)
16. Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, et al. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflamm Bowel Dis 2007;13:984-92. (Pubitemid 47309970)
17. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004;126:414-24. (Pubitemid 38182298)
18. Israeli E, Grotto I, Gilburd B, Balicer RD, Goldin E, Wiik A, et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005;54:1232-6. (Pubitemid 41192480)
19. Desir B, Amre DK, Lu SE, Ohman-Strickland P, Dubinsky M, Fisher R, et al. Utility of serum antibodies in determining clinical course in pediatric Crohn's disease. Clin Gastroenterol Hepatol 2004;2:139-46. (Pubitemid 38180468)
20. Petersen AM, Nielsen EM, Litrup E, Brynskov J, Mirsepasi H, Krogfelt KA. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol 2009;9:171.
21. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
22. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29-32. (Pubitemid 28335486)
23. Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, et al. Modified pouchitis disease activity index, a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003;46:748-53. (Pubitemid 36693394)
24. Hertervig E, Wieslander J, Johansson C, Wiik A, Nilsson A. Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol 1995;30:693-8.
25. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689-99. (Pubitemid 34977074)
26. Ferrante M, Henckaerts L, Joossens M, Pierik M, Joossens S, Dotan N, et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007;56:1394-403. (Pubitemid 47517833)
27. Blom M, Meyer A, Gerner-Smidt P, Gaarslev K, Espersen F. Evaluation of Statens Serum Institut enteric medium for detection of enteric pathogens. J Clin Microbiol 1999;37: 2312-16. (Pubitemid 29277797)
28. Kjaeldgaard P, Nissen B, Lange N, Laursen H. Evaluation of Minibact, a new system for rapid identification of Enterobacteriaceae: comparison of Minibact, Micro-ID, and API 20E with a conventional method as reference. Acta Pathol Microbiol Immunol Scand 1986;94:57-61. (Pubitemid 16100505)
29. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8.
30. Bélard E, Semb S, Ruhwald M, Werlinrud AM, Soborg B, Jensen FK, et al. Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflamm Bowel Dis 2011;17: 2340-9.
31. Teml A, Kratzer V, Schneider B, Lochs H, Norman GL, Gangl A, et al. Anti-Sacchoromyces cerevisiae antibodies: a stable marker for Crohns's disease during steroid and 5-aminosaliclic acid tretamen. Am J Gastroenterol 2003; 98:2226-31. (Pubitemid 37305363)
32. Mow WS. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot sutdy. Dig Dis Sci 2004;49:1280-6. (Pubitemid 39178101)
33. Henckaerts L, Pierik M, JoossensM, FerranteM, Rutgeerts P, Vermeire S. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease. Gut 2007;56:1536-42. (Pubitemid 350033192)